# Global Partners LP: financial statements, quarterly

GLP · NYSE · CIK 1323468 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/glp.md) · [Financials](/companies/glp/financials.md) · [Filings](/companies/glp/filings.md) · [Insiders](/companies/glp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/glp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,807](/filings/0001558370-24-015020.md) | [2,313 d](/filings/0001104659-26-021381.md) | [2,203](/filings/0001558370-25-006925.md) | [2,282](/filings/0001558370-25-010710.md) | [2,136](/filings/0001104659-25-108244.md) | [2,066 d](/filings/0001104659-26-021381.md) | [2,174](/filings/0001104659-26-057689.md) | [2,085](/filings/0001104659-26-092496.md) | [2,243](/filings/0001104659-25-108244.md) | [2,210 d](/filings/0001104659-26-021381.md) | [2,387](/filings/0001104659-26-057689.md) | [2,930](/filings/0001104659-26-092496.md) |
| Cost of revenue | $m | [3,993](/filings/0001558370-24-015020.md) | [4,129 d](/filings/0001104659-26-021381.md) | [3,930](/filings/0001558370-25-006925.md) | [4,122](/filings/0001558370-25-010710.md) | [4,136](/filings/0001104659-25-108244.md) | [3,917 d](/filings/0001104659-26-021381.md) | [4,337](/filings/0001104659-26-057689.md) | [4,355](/filings/0001104659-26-092496.md) | [4,423](/filings/0001104659-25-108244.md) | [4,385 d](/filings/0001104659-26-021381.md) | [4,990](/filings/0001104659-26-057689.md) | [6,463](/filings/0001104659-26-092496.md) |
| Gross profit | $m | [229](/filings/0001558370-24-015020.md) | [280 d](/filings/0001104659-26-021381.md) | [215](/filings/0001558370-25-006925.md) | [288](/filings/0001558370-25-010710.md) | [286](/filings/0001104659-25-108244.md) | [269 d](/filings/0001104659-26-021381.md) | [255](/filings/0001104659-26-057689.md) | [272](/filings/0001104659-26-092496.md) | [271](/filings/0001104659-25-108244.md) | [263 d](/filings/0001104659-26-021381.md) | [332](/filings/0001104659-26-057689.md) | [329](/filings/0001104659-26-092496.md) |
| Selling, general and administrative | $m | [63.5](/filings/0001558370-24-015020.md) | [81.3 d](/filings/0001104659-26-021381.md) | [69.8](/filings/0001558370-25-006925.md) | [72.4](/filings/0001558370-25-010710.md) | [70.5](/filings/0001104659-25-108244.md) | [79.4 d](/filings/0001104659-26-021381.md) | [73.7](/filings/0001104659-26-057689.md) | [74.8](/filings/0001104659-26-092496.md) | [76.3](/filings/0001104659-25-108244.md) | [80.9 d](/filings/0001104659-26-021381.md) | [99.4](/filings/0001104659-26-057689.md) | [83.0](/filings/0001104659-26-092496.md) |
| Operating income | $m | [48.0](/filings/0001558370-24-015020.md) | [81.6 d](/filings/0001104659-26-021381.md) | [25.8](/filings/0001558370-25-006925.md) | [83.9](/filings/0001558370-25-010710.md) | [83.5](/filings/0001104659-25-108244.md) | [58.1 d](/filings/0001104659-26-021381.md) | [55.9](/filings/0001104659-26-057689.md) | [60.1](/filings/0001104659-26-092496.md) | [61.4](/filings/0001104659-25-108244.md) | [57.3 d](/filings/0001104659-26-021381.md) | [106](/filings/0001104659-26-057689.md) | [107](/filings/0001104659-26-092496.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.3](/filings/0001558370-24-015020.md) | [5.8 d](/filings/0001104659-26-021381.md) | [0.4](/filings/0001558370-25-006925.md) | [1.8](/filings/0001558370-25-010710.md) | [2.3](/filings/0001104659-25-108244.md) | [0.1 d](/filings/0001104659-26-021381.md) | [1.2](/filings/0001104659-26-057689.md) | [(0.1)](/filings/0001104659-26-092496.md) | [(0.4)](/filings/0001104659-25-108244.md) | [0.4 d](/filings/0001104659-26-021381.md) | [0.8](/filings/0001104659-26-057689.md) | [5.3](/filings/0001104659-26-092496.md) |
| Net income | $m | [26.8](/filings/0001558370-24-015020.md) | [55.3 d](/filings/0001104659-26-021381.md) | [(5.6)](/filings/0001558370-25-006925.md) | [46.1](/filings/0001558370-25-010710.md) | [45.9](/filings/0001104659-25-108244.md) | [23.9 d](/filings/0001104659-26-021381.md) | [18.7](/filings/0001104659-26-057689.md) | [25.2](/filings/0001104659-26-092496.md) | [29.0](/filings/0001104659-25-108244.md) | [25.1 d](/filings/0001104659-26-021381.md) | [70.1](/filings/0001104659-26-057689.md) | [71.0](/filings/0001104659-26-092496.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [1,042](/filings/0001558370-23-018510.md) | [1,098](/filings/0001558370-25-001925.md) | [1,155](/filings/0001558370-24-007310.md) | [1,300](/filings/0001558370-24-011336.md) | [1,125](/filings/0001558370-24-015020.md) | [1,207](/filings/0001104659-26-021381.md) | [1,243](/filings/0001558370-25-006925.md) | [1,215](/filings/0001558370-25-010710.md) | [1,134](/filings/0001104659-25-108244.md) | [1,227](/filings/0001104659-26-092496.md) | [1,708](/filings/0001104659-26-057689.md) | [1,426](/filings/0001104659-26-092496.md) |
| Total assets | $m | [3,051](/filings/0001558370-23-018510.md) | [3,446](/filings/0001558370-25-001925.md) | [3,466](/filings/0001558370-24-007310.md) | [3,829](/filings/0001558370-24-011336.md) | [3,665](/filings/0001558370-24-015020.md) | [3,788](/filings/0001104659-26-021381.md) | [3,819](/filings/0001558370-25-006925.md) | [3,784](/filings/0001558370-25-010710.md) | [3,700](/filings/0001104659-25-108244.md) | [3,851](/filings/0001104659-26-092496.md) | [4,312](/filings/0001104659-26-057689.md) | [4,022](/filings/0001104659-26-092496.md) |
| Current liabilities | $m | [917](/filings/0001558370-23-018510.md) | [983](/filings/0001558370-25-001925.md) | [986](/filings/0001558370-24-007310.md) | [1,183](/filings/0001558370-24-011336.md) | [983](/filings/0001558370-24-015020.md) | [1,000](/filings/0001104659-26-021381.md) | [1,067](/filings/0001558370-25-006925.md) | [1,027](/filings/0001558370-25-010710.md) | [934](/filings/0001104659-25-108244.md) | [1,076](/filings/0001104659-26-092496.md) | [1,523](/filings/0001104659-26-057689.md) | [1,196](/filings/0001104659-26-092496.md) |
| Total liabilities | $m | [2,276](/filings/0001558370-23-018510.md) | [2,645](/filings/0001558370-25-001925.md) | [2,702](/filings/0001558370-24-007310.md) | [3,123](/filings/0001558370-24-011336.md) | [2,942](/filings/0001558370-24-015020.md) | [3,072](/filings/0001104659-26-021381.md) | [3,123](/filings/0001558370-25-006925.md) | [3,098](/filings/0001558370-25-010710.md) | [3,018](/filings/0001104659-25-108244.md) | [3,175](/filings/0001104659-26-092496.md) | [3,601](/filings/0001104659-26-057689.md) | [3,273](/filings/0001104659-26-092496.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [97.1 d](/filings/0001558370-24-015020.md) | [169 d](/filings/0001104659-26-021381.md) | [(183)](/filings/0001558370-25-006925.md) | [24.3 d](/filings/0001558370-25-010710.md) | [123 d](/filings/0001104659-25-108244.md) | [67.2 d](/filings/0001104659-26-021381.md) | [(51.6)](/filings/0001104659-26-057689.md) | [216 d](/filings/0001104659-26-092496.md) | [19.0 d](/filings/0001104659-25-108244.md) | [101 d](/filings/0001104659-26-021381.md) | [(105)](/filings/0001104659-26-057689.md) | [309 d](/filings/0001104659-26-092496.md) |
| Capital expenditure | $m | [17.5 d](/filings/0001558370-24-015020.md) | [34.1 d](/filings/0001104659-26-021381.md) | [16.6](/filings/0001558370-25-006925.md) | [15.6 d](/filings/0001558370-25-010710.md) | [24.3 d](/filings/0001104659-25-108244.md) | [46.8 d](/filings/0001104659-26-021381.md) | [17.9](/filings/0001104659-26-057689.md) | [15.1 d](/filings/0001104659-26-092496.md) | [19.7 d](/filings/0001104659-25-108244.md) | [38.8 d](/filings/0001104659-26-021381.md) | [31.9](/filings/0001104659-26-057689.md) | [35.0 d](/filings/0001104659-26-092496.md) |
| Share repurchases | $m | not reported | [2.8 d](/filings/0001104659-26-021381.md) | not reported | not reported | [3.3 d](/filings/0001104659-25-108244.md) | [3.0 d](/filings/0001104659-26-021381.md) | [0.5](/filings/0001104659-26-057689.md) | [3.0 d](/filings/0001104659-26-092496.md) | [3.8 d](/filings/0001104659-25-108244.md) | [2.6 d](/filings/0001104659-26-021381.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 33,995,563 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092496.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.